Effective development co-operation for Gavi, the Vaccine Alliance is about providing support that improves health sector planning, strengthens national systems, and contributes to health results through more efficient and sustainable implementation of national health plans
Community health office in Ghana.
Credit: Gavi/2012/Doune Porter.
As a founding signatory to the International Health Partnership (IHP+) in 2007, the International Aid Transparency Initiative (IATI) in 2008, and having endorsed the Paris, Accra and Busan compacts, Gavi’s catalytic role in immunisation and global health is guided by these internationally agreed aid effectiveness standards, such as the principles agreed in Busan as outlined below.
Ownership of development priorities by developing countries
Gavi is based on a demand-driven model whereby countries identify their own priorities and choose what Gavi support to apply for based on their national health and immunisation plans. 100% of Gavi’s aid is untied, and up to 97% of Gavi support is based on multiyear commitments. See how countries and Gavi are delivering together for women and children in some of the poorest regions of the world.
Focus on results
Well-spent development aid can save and change lives…Gavi is achieving impressive results and clearly demonstrating the cost-effectiveness of immunisation as a tool for improving global health.
Hillevi Engström, Minister for International Development Cooperation, Sweden
Since 2000, developing countries have immunised an additional 500 million children and prevented more than 7 million deaths with Gavi support. The estimated return on investment in expanded vaccine coverage is approximately 18% - similar to the investment return on primary education. Gavi’s co-financing policy requires countries to contribute to the cost of new vaccines supported by Gavi. As their economies grow, countries eventually graduate from Gavi support and move towards full national financing of their immunisation programmes.
Inclusive development partnerships
Starting from the GAVI Alliance Board to the technical staff of partner organisations who work together to support programme implementation at country level, Vaccine Alliance partners are helping to redress the global inequities in access to vaccines. The private sector advances Gavi’s mission through shaping the vaccine market to reduce prices, ensuring predictable and flexible funding, sharing business expertise, and advocating for the importance of immunisation. The active participation of civil society is critical to scaling up immunisation equity and coverage. A recent internal analysis (2013) of approved Gavi health system strengthening (HSS) grants, for example, found that all countries engaged CSOs in the development and planning of HSS proposals, with the majority including a budget line for CSO-related activities.
Transparency and accountability to each other
Being held accountable for results at country level is a cornerstone of the Gavi model. One way to facilitate this is to publish what is being spent where, and with what results. In 2013, Gavi was ranked as one of the most transparent aid agencies in the world. Improving transparency also helps developing countries manage aid more effectively. This means that each dollar will go as far as possible towards fighting poverty. As a signatory to the IHP+, Gavi also participates in mutual assessments in countries where possible, and increasingly participates in Joint Annual Reviews (JARs) in circumstances where Gavi support is part of a pooled funding mechanism to a country’s health sector by development partners.
Recent multilateral aid assessments and Gavi’s 2011-2015 strategy Mid-Term Review have also demonstrated Gavi’s continuing impact and value-add in global health and development.
For more information on Gavi’s approach to the indicators from the monitoring framework of the Busan Global Partnership, please see our Partnering for effective development co-operation information note.